ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,320.76
0.43%
Dow Jones
42,313.00
0.33%
Gold vs US Dollar
2,659.30
0.04%
Brent Oil
71.76
-0.35%
Bitcoin
65,841.01
-0.05%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Zai Lab Ltd (ZLAB) Share Price

ZLAB Zai Lab Ltd

23.63
1.03 (4.56%)
28 Sep 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Zai Lab Ltd NASDAQ:ZLAB NASDAQ Depository Receipt  ADS
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   1.03 4.56 23.63 23.30 24.18 24.46 23.01 23.69 1,002,244 04:00:13   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 266.72M -334.62M - N/A 2.25B
 Type  Size  Price  Time  Units 
 20 315 23.63 20:00:04 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ZLAB News
26/09/202420:52EDGAR2Form 144 - Report of proposed sale of securities
19/09/202421:55EDGAR2Form 144 - Report of proposed sale of securities
17/09/202418:32BWZai Lab to Present Preclinical Data of ZL-1503, an IL-13/IL-31 Bispecific Antibody for the Treatment of Atopic Dermatitis, at EADV Congress 2024
05/09/202421:13EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
03/09/202417:12EDGAR2Form 144 - Report of proposed sale of securities
27/08/202413:30BWZai Lab to Present Preliminary Data From Phase 1 Trial of ZL-1218, an Investigational Anti-CCR8 Antibody for the Treatment of Advanced Solid Tumors, at ESMO Congress 2024
22/08/202412:30BWZai Lab Announces Participation in September Investor Conferences
Period
Draw mode
Data Downloads for ZLAB

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Zai Lab Ltd Articles